Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
NCT00488878 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2026-02-13
Summary
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
Conditions
- Low Grade Ovarian Serous Adenocarcinoma
- Malignant Ovarian Neoplasm
- Ovarian Carcinoma
- Primary Peritoneal Carcinoma
- Primary Peritoneal Low Grade Serous Adenocarcinoma
- Psammocarcinoma
Interventions
- PROCEDURE
-
Biospecimen Collection
Patients' residual tissue samples are collected
- OTHER
-
Electronic Health Record Review
Medical records are reviewed
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
David M Gershenson · M.D. Anderson Cancer Center
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-19
- Primary Completion
- 2034-05-01
- Completion
- 2035-05-01
Countries
- United States
Study Locations
More Related Trials
-
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
NCT01372787 ·Status: UNKNOWN
-
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT01295489 ·Status: COMPLETED
-
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
NCT00587093 ·Status: COMPLETED ·Phase: NA
-
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
NCT03976999 ·Status: RECRUITING ·Phase: NA
-
Registry Platform Ovarian and Endometrial Cancer
NCT05129969 ·Status: RECRUITING
-
M. D. Anderson Symptom Inventory - Ovarian Cancer
NCT01037751 ·Status: COMPLETED
-
New Biomarkers Evaluating Ovarian Cancer
NCT01466049 ·Status: COMPLETED
-
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
NCT06969833 ·Status: RECRUITING ·Phase: NA
-
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
NCT00582205 ·Status: TERMINATED ·Phase: PHASE2
-
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
NCT02973750 ·Status: COMPLETED
-
Research Study in Patients With Advanced Ovarian Epithelial Cancer
NCT00053235 ·Status: WITHDRAWN
-
Letrozole in Patients With Ovarian Tumors
NCT00505661 ·Status: TERMINATED ·Phase: PHASE2
-
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00801320 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
NCT00002538 ·Status: COMPLETED ·Phase: PHASE2
-
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients
NCT05114421 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
NCT00626873 ·Status: COMPLETED ·Phase: PHASE1
-
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00897039 ·Status: UNKNOWN
-
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02050009 ·Status: WITHDRAWN ·Phase: PHASE1
-
Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia
NCT04001023 ·Status: RECRUITING ·Phase: NA
-
Ovarian Cancer Patient Questionnaire on Genetic Testing
NCT00486707 ·Status: COMPLETED
-
Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
NCT02785731 ·Status: COMPLETED
-
Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
NCT01468909 ·Status: COMPLETED ·Phase: PHASE2
-
PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
NCT00085384 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
NCT00987649 ·Status: COMPLETED
-
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases
NCT01048814 ·Status: COMPLETED